Ocuphire Pharma (OCUP) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Ocuphire Pharma (NASDAQ:OCUP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.70%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$80,260.00Number OfInsiders Selling(Last 12 Months)0 Get OCUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocuphire Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OCUP Insider Buying and Selling by Quarter Ad DTIEver heard of this 8-day bitcoin profit window? Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. Ocuphire Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/22/2024Ashwath JayagopalInsiderBuy3,500$1.76$6,160.00 3/21/2024Joseph K SchachleCOOBuy2,000$2.05$4,100.00 3/21/2024Nirav S JhaveriCFOBuy10,000$2.10$21,000.00 3/18/2024George MagrathCEOBuy25,000$1.96$49,000.00 (Data available from 1/1/2013 forward) OCUP Insider Trading Activity - Frequently Asked Questions Who is on Ocuphire Pharma's Insider Roster? The list of insiders at Ocuphire Pharma includes Ashwath Jayagopal, George Magrath, James S J Manuso, Jay Pepose, Joseph K Schachle, Mina Sooch, and Nirav S Jhaveri. Learn more on insiders at OCUP. What percentage of Ocuphire Pharma stock is owned by insiders? 8.70% of Ocuphire Pharma stock is owned by insiders. Learn more on OCUP's insider holdings. Which Ocuphire Pharma insiders have been buying company stock? The following insiders have purchased OCUP shares in the last 24 months: Ashwath Jayagopal ($6,160.00), George Magrath ($49,000.00), Joseph K Schachle ($4,100.00), and Nirav S Jhaveri ($21,000.00). How much insider buying is happening at Ocuphire Pharma? Insiders have purchased a total of 40,500 OCUP shares in the last 24 months for a total of $80,260.00 bought. Ocuphire Pharma Key ExecutivesMr. George Magrath M.B.A. (Age 40)M.D., M.S., CEO & Director Compensation: $625.07kMr. Bernhard Hoffmann M.B.A. (Age 68)Senior Vice President of Corporate Development & Secretary Compensation: $434.1kDr. Jay S. Pepose M.D. (Age 69)Ph.D., Chief Medical Advisor & Director Compensation: $392kMs. Amy Zaremba Rabourn C.P.A. (Age 43)MAcc, Senior Vice President of Finance Compensation: $434.1kMr. Nirav Suresh Jhaveri C.F.A. (Age 46)Chief Financial Officer Mr. Joseph K. Schachle MBA (Age 59)Chief Operating Officer Dr. Ashwath Jayagopal Ph.D. (Age 42)Chief Scientific & Development Officer Ms. Bindu ManneHead of Market Development & CommercializationMr. Erik SimsDirector & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Context Therapeutics Insider Selling Alto Neuroscience Insider Selling Rani Therapeutics Insider Selling Journey Medical Insider Selling Monopar Therapeutics Insider Selling Coya Therapeutics Insider Selling Immunic Insider Selling Avalo Therapeutics Insider Selling Milestone Pharmaceuticals Insider Selling Anixa Biosciences Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:OCUP) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocuphire Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OCUP Stock Alerts